Before Reyna, Prost, and Schall. Appeal from the United States District Court for the Northern District of California. Summary: Claims are patent-eligible under 35 U.S.C. § 101 where the written description discloses...more
PFIZER INC. v. SANOFI PASTEUR INC. -
Before Lourie, Bryson, and Stark. Appeal from the Patent Trial and Appeal Board....more
4/10/2024
/ Appeals ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Life Sciences ,
Merck ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pfizer ,
Pharmaceutical Industry ,
Prior Art ,
Sanofi
ARTHREX, INC. V. SMITH & NEPHEW ET AL.
Before Dyk, Chen, and Stoll. Appeal from the U.S. Patent and Trademark Office -
Summary: The Board’s invalidity decision does not need to track the exact wording in the IPR...more
Federal Circuit Summaries -
Before Moore, Wallach, and Taranto. Appeal from the Patent Trial and Appeal Board.
Summary: The Supreme Court’s decision in SAS Institute Inc. v. Iancu requires the Board in an instituted...more
7/3/2018
/ Adidas ,
Appeals ,
Final Written Decisions ,
Inter Partes Review (IPR) Proceeding ,
Nike ,
Obviousness ,
Partial Institution ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Remand ,
SAS Institute Inc. v Iancu
Federal Circuit Summaries -
Before Moor, Mayer, and Stoll. Appeal from the patent Trial and Appeal Board
Summary: The broadest reasonable interpretation of a claim term cannot be so broad that it is inconsistent with...more